Akero Therapeutics, Inc. (AKRO) — Analyst outlook / Analyst consensus target is. Based on 14 analyst ratings, the consensus is bullish — 10 Buy, 4 Hold.
The consensus price target is $46.00 (low: $38.00, high: $56.00), representing a downside of 15.8% from the current price $54.65.
AKRO Stock — 12-Month Price Forecast
$46.00
▼ -15.83% Downside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for Akero Therapeutics, Inc., the average price target is $46.00, with a high forecast of $56.00, and a low forecast of $38.00.
The average price target represents a -15.83% change from the last price of $54.65.
Highest Price Target
$56.00
Average Price Target
$46.00
Lowest Price Target
$38.00
AKRO Analyst Ratings
Buy
Based on 14 analysts giving stock ratings to Akero Therapeutics, Inc. in the past 3 months
